FIGURE
Fig. S6
- ID
- ZDB-FIG-140422-52
- Publication
- Holly et al., 2014 - Sfrp1a and Sfrp5 function as positive regulators of Wnt and BMP signaling during early retinal development
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. S6
Dorsomorphin treatment enhances BMP ligand expression. In order to analyze regulation of BMP ligand expression, BMP signaling was inhibited with 100 μM dorsomorphin. To confirm BMP inhibition tbx5a expression was analyzed using in situ hybridization. Loss of tbx5a expression at 28 hpf indicates loss of BMP signaling (A-B). Expression of BMP ligands, gdf6a and bmp4 at 28 hpf, analyzed using in situ hybridization, is increased upon dorsomorphin treatment (C-F). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Reprinted from Developmental Biology, 388(2), Holly, V.L., Widen, S.A., Famulski, J.K., and Waskiewicz, A.J., Sfrp1a and Sfrp5 function as positive regulators of Wnt and BMP signaling during early retinal development, 192-204, Copyright (2014) with permission from Elsevier. Full text @ Dev. Biol.